A
41.03
0.00 (0.00%)
| Previous Close | 41.03 |
| Open | 41.03 |
| Avg. Volume (3M) | 6,474,715 |
| Market Cap | 5,252,712,960 |
| Price / Earnings (TTM) | 38.35 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2026 |
| Profit Margin | -28.83% |
| Operating Margin (TTM) | -49.96% |
| Diluted EPS (TTM) | -1.80 |
| Quarterly Revenue Growth (YOY) | -3.20% |
| Total Debt/Equity (MRQ) | 285.94% |
| Current Ratio (MRQ) | 4.08 |
| Operating Cash Flow (TTM) | -8.29 M |
| Levered Free Cash Flow (TTM) | 45.63 M |
| Return on Assets (TTM) | -14.20% |
| Return on Equity (TTM) | -103.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Apellis Pharmaceuticals, Inc. | Mixed | Bearish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| APLS | 5 B | - | 38.35 | - |
| TERN | 6 B | - | - | 6.08 |
| TRML | 1 B | - | - | 4.76 |
| RXRX | - | - | - | 2.36 |
| IONS | - | - | - | 11.92 |
| VKTX | - | - | - | 6.21 |
AIStockmoo Score
| Value 35% | -0.5 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -0.5 |
| Timing 35% | 0.0 |
| AI Technical info | NA |
| Technical Oscillators info | 0.0 |
| Technical Moving Averages info | 0.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| News Mood info | NA |
| Environment | ×1.21 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -22.4% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | -2.5 |
| Final Score | -0.21 |
Select this tab to load the latest available analysis.
|
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 13.69% |
| % Held by Institutions | 104.60% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |